Skip header and navigation

3 records – page 1 of 1.

Intraperitoneal Cancer Therapy

https://libcat.nshealth.ca/en/permalink/provcat28434
edited by C. William Helm, Robert P. Edwards. --Totowa, NJ: Humana Press , c2007.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Helm, C. William
Other Authors
Edwards, Robert P
Responsibility
edited by C. William Helm, Robert P. Edwards
Place of Publication
Totowa, NJ
Publisher
Humana Press
Date of Publication
c2007
Series Title
Current clinical oncology
ISBN
9781597451956
Subjects (MeSH)
Colorectal Neoplasms - therapy
Hyperthermia, Induced
Ovarian Neoplasms - therapy
Subjects (LCSH)
Abdomen - Surgery
Cancer - Surgery
Gynecology
Notes
"This collaborative work is the result of a gathering of some of the leaders in the field of intraperitoneal chemotherapy for ovarian cancer and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis at an international symposium held at the University of Louisville, Kentucky, in May 2005. All the speakers at that symposium have contributed chapters to this work"-- P. v.
Contents
Management of ovarian cancer : the theory -- Management of ovarian cancer : clinical trials-- A systematic review and meta-analysis of randomized trials -- Immunobiology and intraperitoneal immunobiologics in ovarian cancer -- Intraperitoneal chemotherapy : technique and complications -- Hyperthermia and chemotherapy : the science -- Hyperthermic intraperitoneal chemotherapy in nongynecologic cancers -- Peritoneal carcinomatosis of colorectal origin -- Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian cancer : experience in France -- Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian cancer : world experience -- Techniques of delivering hyperthermic intraperitoneal chemotherapy -- Future directions in the delivery of hyperthermic intraperitoneal chemotherapy.
Format
e-Book
Location
Online
Less detail

Minimal residual disease and circulating tumor cells in breast cancer

https://libcat.nshealth.ca/en/permalink/provcat31178
Michail Ignatiadis, Christos Sotiriou, Klaus Pantel, editors. --Berlin, Heidelberg: Springer , c2012.
Available Online
View e-Book
Location
Online
Most deaths from carcinomas are caused by the hematogenous dissemination of cancer cells to distant organs and the eventual development of metastases. When found in the bone marrow or peripheral blood of carcinoma patients, occult cancer cells are referred to as disseminated tumor cells (DTCs) or circulating tumor cells (CTCs). CTCs and DTCs are considered surrogates of minimal residual disease, i.e., the presence of malignant cells in distant organs that are undetectable by conventional imagin…
Available Online
View e-Book
Other Authors
Ignatiadis, Michail
Sotiriou, Christos
Pantel, Klaus
Responsibility
Michail Ignatiadis, Christos Sotiriou, Klaus Pantel, editors
Place of Publication
Berlin, Heidelberg
Publisher
Springer
Date of Publication
c2012
Physical Description
1 online resource (xiv, 253 p. : 35 ill., 28 ill. in color)
Series Vol.
195
Series Title
Recent results in cancer research
ISBN
9783642281600
Subjects (MeSH)
Breast Neoplasms - diagnosis
Neoplasm Metastasis
Neoplasm, Residual
Neoplastic Cells, Circulating
Subjects (LCSH)
Oncology
Gynecology
Cancer - Surgery
Pathology
Abstract
Most deaths from carcinomas are caused by the hematogenous dissemination of cancer cells to distant organs and the eventual development of metastases. When found in the bone marrow or peripheral blood of carcinoma patients, occult cancer cells are referred to as disseminated tumor cells (DTCs) or circulating tumor cells (CTCs). CTCs and DTCs are considered surrogates of minimal residual disease, i.e., the presence of malignant cells in distant organs that are undetectable by conventional imaging and laboratory tests used for tumor staging after curative surgery of the primary tumor. In this book, leading investigators in the field provide up-to-date information on a series of important questions, including: How can the study of minimal residual disease and CTCs help us to better understand breast cancer metastasis? What technologies are available for the detection and characterization of CTCs and DTCs, and what are their relative merits? How are DTCs and CTCs relevant to clinical research and practice? What is the role of other blood-based biomarkers such as circulating endothelial cells and circulating nucleic acids? What are the challenges in drug and biomarker co-development and the use of CTCs for companion diagnostic development? This book will be of interest and assistance to all who are engaged in the modern management of breast cancer.
Contents
Part I. Introduction -- Part II. Minimal Residual Disease and Breast Cancer Metastasis -- Part III. Technologies for Circulating Tumor Cell and Disseminated Tumor Cell Detection and Characterization -- Part IV. Other Blood-Based Biomarkers -- Part V. Disseminated Tumor Cells and Circulating Tumor Cells in Breast Cancer Clinical Research and Practice -- Part VI. Drug and Circulating Tumor Cell Co-development -- References.
Format
e-Book
Location
Online
Less detail

Oncoplastic and Reconstructive Surgery for Breast Cancer : The Institut Curie Experience

https://libcat.nshealth.ca/en/permalink/provcat28986
edited by A. Fitoussi, MG Berry, B. Couturaud, R. J. Salmon. --Berlin, Heidelberg: Springer , c2009.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Fitoussi, A
Other Authors
Berry, MG
Couturaud, B
Salmon, R. J
Responsibility
edited by A. Fitoussi, MG Berry, B. Couturaud, R. J. Salmon
Place of Publication
Berlin, Heidelberg
Publisher
Springer
Date of Publication
c2009
ISBN
9783642001444
Subjects (MeSH)
Breast Neoplasms - surgery
Mammaplasty - methods
Reconstructive Surgical Procedures
Subjects (LCSH)
Gynecology
Cancer - Surgery
Format
e-Book
Location
Online
Less detail